Embecta Corp. insider trading

EMBCNASDAQ

$5.65-0.14 (-2.42%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-60.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

DKDevdatt KurdikarPresident and CEO1.4206%of company
JEJacob ElguiczeSVP and CFO0.5456%of company
JZJeffrey Z. MannPres, Pharm Svc&Prod Mgmt, CLO0.464%of company
RJRobert J. HombachDirector0.1934%of company
SCShaun CurtisSVP, Global Manuf./Sup. Chain0.1682%of company
DFDavid F. MelcherDirector0.153%of company
JCJean CasnerChief Human Resources Officer0.1516%of company
AMAnthony M. RothVP, Chief Accounting Officer0.1391%of company
CRChristopher R. ReidyDirector0.1238%of company
CPClaire PomeroyDirector0.1167%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
EMBC	Milton Mayo MorrisDirector	Open market sell$37K	-10.5%	$5.88	$37K	Sep 4, 2026	Sep 8, 2026
EMBC	Devdatt KurdikarPresident and CEO	Open market purchase$141K	+3.9%	$4.70	$141K	Aug 12, 2026	Aug 13, 2026
EMBC	Jacob ElguiczeSVP and CFO	Open market purchase$93.4K	+6.9%	$4.67	$93.4K	Aug 12, 2026	Aug 13, 2026
EMBC	Jeffrey Z. MannPres, Pharm Svc&Prod Mgmt, CLO	Open market purchase$99.8K	+8.2%	$4.99	$99.8K	Aug 12, 2026	Aug 13, 2026
EMBC	Robert J. HombachDirector	Open market purchase$224K	+69.7%	$4.97	$224K	Aug 12, 2026	Aug 13, 2026

End of history · 5 transactions